Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against
Pseudomonas aeruginosa
dynamic infection model
pharmacodynamics
pharmacokinetics
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
13 Jan 2022
13 Jan 2022
Historique:
received:
02
12
2021
revised:
05
01
2022
accepted:
11
01
2022
entrez:
21
1
2022
pubmed:
22
1
2022
medline:
22
1
2022
Statut:
epublish
Résumé
We evaluated piperacillin-tazobactam and tobramycin regimens against
Identifiants
pubmed: 35052977
pii: antibiotics11010101
doi: 10.3390/antibiotics11010101
pmc: PMC8772788
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Health and Medical Research Council
ID : GNT1184428
Organisme : National Health and Medical Research Council
ID : GNT1099452
Organisme : National Health and Medical Research Council
ID : GNT1159579
Références
Lancet Infect Dis. 2014 Jun;14(6):498-509
pubmed: 24768475
Clin Pharmacol Ther. 2021 Apr;109(4):928-941
pubmed: 33565627
J Intensive Care Med. 2017 Jan;32(1):25-37
pubmed: 26772199
Front Microbiol. 2011 Apr 05;2:65
pubmed: 21747788
Intensive Care Med. 2004 May;30(5):976-9
pubmed: 15057512
Antimicrob Agents Chemother. 2015 Nov;59(11):7018-26
pubmed: 26349823
Antimicrob Agents Chemother. 2013 Dec;57(12):5811-9
pubmed: 24002098
Antimicrob Agents Chemother. 2011 May;55(5):1906-11
pubmed: 21357294
Clin Pharmacol Ther. 2021 Apr;109(4):856-866
pubmed: 33523464
Br J Clin Pharmacol. 1997 Feb;43(2):125-35
pubmed: 9131944
J Antimicrob Chemother. 2020 Sep 1;75(9):2633-2640
pubmed: 32585693
Yonsei Med J. 2010 Jan;51(1):111-6
pubmed: 20046523
Antimicrob Agents Chemother. 1992 Dec;36(12):2577-83
pubmed: 1482127
Rev Soc Bras Med Trop. 2013 May-Jun;46(3):299-303
pubmed: 23856877
J Clin Pharm Ther. 2021 Apr;46(2):424-432
pubmed: 33135261
Clin Infect Dis. 2014 Apr;58(8):1072-83
pubmed: 24429437
Am J Respir Crit Care Med. 2017 Oct 1;196(7):856-863
pubmed: 28345952
Antimicrob Agents Chemother. 2018 Mar 27;62(4):
pubmed: 29437610
Microb Pathog. 2021 Apr;153:104789
pubmed: 33556480
Eur J Drug Metab Pharmacokinet. 2018 Apr;43(2):155-170
pubmed: 29027128
J Intensive Care. 2020 Nov 23;8(1):86
pubmed: 33292582
Antimicrob Agents Chemother. 2000 Dec;44(12):3322-7
pubmed: 11083635
J Antimicrob Chemother. 2016 Sep;71(9):2509-20
pubmed: 27231278
Diagn Microbiol Infect Dis. 2017 Feb;87(2):180-187
pubmed: 27863948
BMC Infect Dis. 2020 Jun 20;20(1):430
pubmed: 32563242
Am J Respir Crit Care Med. 2016 Sep 15;194(6):681-91
pubmed: 26974879
Antimicrob Agents Chemother. 2017 May 24;61(6):
pubmed: 28373189
J Antimicrob Chemother. 2018 Mar 1;73(3):564-568
pubmed: 29216348
Drugs Context. 2018 May 29;7:212527
pubmed: 29872449
N Engl J Med. 2017 Jun 8;376(23):2235-2244
pubmed: 28528569
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Am J Infect Control. 1990 Aug;18(4):250-6
pubmed: 2403216
Crit Care Med. 2008 Aug;36(8):2433-40
pubmed: 18596628
Int J Antimicrob Agents. 2010 Oct;36(4):332-9
pubmed: 20685085
Diagn Microbiol Infect Dis. 2018 May;91(1):69-76
pubmed: 29395712
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28893782
Antimicrob Agents Chemother. 2019 Dec 20;64(1):
pubmed: 31636062
J Bacteriol. 2005 Aug;187(15):5341-6
pubmed: 16030228
Adv Clin Exp Med. 2020 Aug;29(8):993-1000
pubmed: 32783408
Int J Antimicrob Agents. 2014 Feb;43(2):105-13
pubmed: 24359838
Antimicrob Agents Chemother. 2016 Dec 27;61(1):
pubmed: 27821448
Antimicrob Agents Chemother. 2015 Apr;59(4):2286-98
pubmed: 25645842
Eur J Hosp Pharm. 2020 Mar;27(e1):e30-e35
pubmed: 32296502
Clin Infect Dis. 2002 Mar 1;34(5):634-40
pubmed: 11823954
J Clin Microbiol. 2021 Nov 18;59(12):e0021321
pubmed: 34550809
Crit Care. 2015 Jan 30;19:28
pubmed: 25632974
Crit Care. 2019 Mar 29;23(1):104
pubmed: 30925922
Int J Antimicrob Agents. 2008 Dec;32(6):494-8
pubmed: 18804348
Front Pharmacol. 2021 Oct 29;12:770518
pubmed: 34776982
Crit Care Explor. 2021 Jun 11;3(6):e0446
pubmed: 34136822
J Antimicrob Chemother. 2016 Nov;71(11):3157-3167
pubmed: 27521357
Pharm Res. 2016 May;33(5):1115-25
pubmed: 26786016
Pharmaceutics. 2021 Aug 31;13(9):
pubmed: 34575456
Clin Infect Dis. 1998 Jan;26(1):1-10; quiz 11-2
pubmed: 9455502
PLoS One. 2021 Jan 22;16(1):e0244966
pubmed: 33481817
J Antimicrob Chemother. 2019 Jun 1;74(6):1761-1762
pubmed: 30989229
Crit Care Med. 2014 Oct;42(10):2178-87
pubmed: 25054674
Eur J Pharm Sci. 2018 Dec 1;125:23-27
pubmed: 30218696
J Glob Antimicrob Resist. 2021 Sep;26:55-63
pubmed: 34023531
Am J Health Syst Pharm. 2015 Aug 15;72(16):1357-64
pubmed: 26246292
J Bacteriol. 1993 Sep;175(18):5798-805
pubmed: 8376327
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29463528
Front Microbiol. 2012 Nov 28;3:408
pubmed: 23233851
Chest. 2020 Sep;158(3):929-938
pubmed: 32446623
Crit Care. 2014 Aug 13;18(5):480
pubmed: 25405992
J Antimicrob Chemother. 2015 Mar;70(3):818-26
pubmed: 25381167
Jpn J Antibiot. 2000 Apr;53(4):194-200
pubmed: 10868299
Clin Pharmacol Ther. 2021 Apr;109(4):892-904
pubmed: 33570163
Int J Antimicrob Agents. 2018 Apr;51(4):594-600
pubmed: 29277531
Antimicrob Agents Chemother. 1982 Jun;21(6):1003-6
pubmed: 6810755
mBio. 2015 Oct 27;6(6):e01603-15
pubmed: 26507235
Clin Infect Dis. 2013 Jan;56(2):245-7
pubmed: 23074312